Archives

HBox Receives Strategic Growth Investment from Charlesbank Technology Opportunities Fund

Charlesbank

Boston, MA – December 19, 2025: HBox (“HBox” or the “Company”), a leading virtual care platform for specialty practices, announced that it has received a growth investment from Charlesbank’s Technology Opportunities Fund (“TOF”) II. Amid rising chronic disease prevalence, expanding reimbursement for outcome-focused virtual care and innovative new ways for treating patients between visits, specialty practices are seeking scalable ways to extend treatment beyond the clinic. Charlesbank’s investment provides capital to help HBox advance key initiatives, including expanding its virtual care capabilities, furthering its mission to transform care delivery for patients with high-risk chronic conditions, and positioning itself as the virtual care partner to the specialty practice of the future. The transaction closed on December 17, 2025.

HBox is led by BanuPrasad Dhanakoti (Chief Executive Officer), Sandeep Subramanya (Chief Operating Officer) and Mohammed Ali (Chief Revenue Officer), who co-founded the Company. HBox delivers an integrated, AI-powered virtual care platform that leverages connected medical devices, next-generation patient-engagement tools and care services that create a virtual clinic within a clinic, enabling cardiology, pulmonology, nephrology and other specialty clinics to continue care seamlessly outside of in-person care settings. HBox aggregates real-time vitals, patient actions and clinical documentation into a unified system that allows physicians to efficiently manage large chronic populations while maintaining high-touch patient care.

“Today marks an important step forward for HBox and for the patients and clinicians we support,” said Banu Dhanakoti. “For cardiac patients in particular, timely monitoring and personalized care plans can help prevent hospitalizations and provide families with greater confidence in day-to-day condition management. With Charlesbank’s TOF team behind us, we can continue strengthening our offering and advancing a virtual care model that seeks to bring the cardiology clinic of the future into today’s specialty practices – enhancing quality and continuity of care without adding burden to clinics.”

Since its founding, HBox has delivered a fast pace of innovation and high service quality to customers, resulting in rapid customer growth and high patient compliance rates. Today, HBox is a mission-critical partner to independent specialty practices across the country.

“Preventative, virtual and continuous care is the future of healthcare for both improving outcomes and managing costs,” said Michael Zirngibl, Principal at Charlesbank. “We are excited to back Banu, Sandeep, Mo and the team as they continue to expand HBox’s innovative virtual ‘clinic within a clinic’ offering.”

“Remote monitoring and virtual care are becoming standard in many specialties, yet most practices lack the technology and staff to run these programs on their own,” added Hiren Mankodi, Co-Head of Charlesbank’s Technology Opportunities team. “HBox’s combination of software, services and specialty focus positions the Company to be that infrastructure at scale.”

Kaizen Equity Partners served as exclusive financial advisor to HBox, with K&L Gates serving as its counsel. Brown Gibbons Lang & Company served as financial advisor to Charlesbank, with Mintz and McDermott Will & Schulte as counsel.

Categories: News

Tags:

Bridgepoint Group launches its first private wealth offering

Bridgepoint
  • Marks the launch of the Group’s Private Wealth platform, with €200 million already raised and a mission to open access to the middle market for eligible individual investors.
  • Brings together a diversified portfolio of privately owned businesses in Europe and North America, enabling eligible investors to invest alongside Bridgepoint and Energy Capital Partners in sectors driving long-term economic growth.

 

Bridgepoint Group, one of the world’s leading mid-market investors, today announces the launch of its Private Wealth platform. With €200 million already raised, this marks a significant step in the Group’s ambition to provide access to private markets for eligible individual investors.

Overview

Both Bridgepoint Generations and Bridgepoint Generaciones provide eligible investors with the opportunity to invest directly alongside Bridgepoint in a diversified portfolio of privately owned mid-market businesses across Europe and North America.

The middle market has long been Bridgepoint’s home, a segment made up of companies substantial enough to shape economies yet agile enough to innovate and grow rapidly. Often founder- or family-led, these businesses are at pivotal points in their growth journey, offering compelling opportunities that have historically been difficult for individual investors to access.

The platform provides investors with access to the same opportunities as Bridgepoint’s institutional clients – including stakes in businesses such as Kyriba, a global leader in cloud-based liquidity management software; RoC Skincare, one of the largest independent skincare brands; PEI Group, a business intelligence company; and Meristem, one of the fastest-growing crop input companies in North America. Together, the products build on Bridgepoint’s 40-year track record of investing in high-quality, resilient companies that are shaping the global economy, offering exposure to long-term growth themes including energy transition, healthcare, advanced industrials, technology and services.

Bridgepoint Generations

Bridgepoint Generations is an open-ended strategy that combines investments from across Bridgepoint and Energy Capital Partners’ flagship funds in a single, diversified portfolio. It provides eligible investors with access to Bridgepoint’s private equity and energy transition strategies, including energy-transition projects developed through ECP. Once fully invested, the fund is expected to comprise approximately 80–100 companies and is fully funded from launch – unlike traditional closed-ended structures.

Bridgepoint Generations has been established in partnership with S64, with support from Simpson Thacher & Bartlett LLP and Arendt & Medernach SA as legal counsel, Carne Group as Alternative Investment Fund Manager, and Brown Brothers Harriman (BBH) as administrator and custodian.

Bridgepoint Generaciones

Launched in Spain, Bridgepoint Generaciones is a closed-ended fund focused exclusively on Bridgepoint’s European private equity strategies. Building on the Generations product, it combines the firm’s global scale, deep sector expertise and strong local presence to offer a tailored investment opportunity for eligible Spanish investors.

Once fully invested, the fund is expected to comprise approximately 30–40 European companies and has a three-year investment period.

As Bridgepoint’s first locally tailored investment product in Spain – a market where the firm has been investing for over 33 years, supporting and transforming leading companies such as Dorna Sports, Rovensa and Samy Alliance – the initiative underscores its long-term commitment to the region and ambition to extend its institutional capabilities to private wealth investors and intermediaries.

Bridgepoint Generaciones has been established in partnership with Amchor Investment Strategies, acting as Alternative Investment Fund Manager, with support from Simpson Thacher & Bartlett LLP as legal counsel.

Together, Bridgepoint Generations and Bridgepoint Generaciones represent a major step in the Group’s ambition to broaden access to private markets globally.

Speaking about the launch, Raoul Hughes, Chief Executive of Bridgepoint Group, said:

“For forty years we’ve been connecting great companies with the capital and expertise they need to grow. Through our private wealth offering, we’re opening that opportunity to more investors, bringing together our investment capabilities in a single platform that reflects the very best of what we do. This is about helping individuals invest alongside us in the companies shaping the world of tomorrow.”

Bridgepoint Group plans to expand its private wealth offering over time to include additional strategies such as credit, enabling eligible investors to access different parts of the risk-return spectrum.

Bridgepoint Group is one of the world’s leading quoted private asset growth investors, specialising in private equity, infrastructure and private credit.

With over $86 billion of assets under management and a strong local presence in Europe, North America and Asia, we combine global scale with local market insight and sector expertise, consistently delivering strong returns through cycles.

Bridgepoint Advisers Limited, a subsidiary of Bridgepoint Group plc, is authorised and regulated by the Financial Conduct Authority.

Categories: News

Tags:

Bridgepoint Group adds Newbury Partners team to expand into fast-growing secondaries market and strengthen global alternatives platform

Bridgepoint
  • Bridgepoint adds a secondaries platform, expanding product offering and market reach
  • Highly experienced team enables Bridgepoint to capitalise on fast-growing secondaries market
  • Team expected to join in early 2026

 

Bridgepoint Group plc today announces it has agreed to add the team from Newbury, a leading mid-market secondaries investment firm with more than $4 billion of Assets under Management (“AUM”) as it continues to build a globally scaled, diversified alternatives platform. Upon satisfaction of customary closing conditions and conditions precedent, the experienced Newbury team is expected to join Bridgepoint in early 2026, expanding the Group’s capabilities into the attractive and fast-growing secondaries segment. The team brings established client relationships and, importantly, nearly two decades of proprietary data and performance history from the secondaries market, enhancing Bridgepoint’s analytical and investment capabilities.

Newbury specialises in acquiring limited partnership interests in established buyout, growth equity and venture capital funds. Founded in 2006, the team have raised over $6.5 billion in committed capital across six dedicated funds and have invested in more than 700 underlying private equity fund interests on behalf of over 250 limited partners worldwide, returning more than $5 billion in distributions since inception.

The team will manage Newbury’s most recent fund and will act as sub-advisor to its predecessor funds, adding $4.3bn of AUM to the Group at closing. In return for such sub-advisory services, Bridgepoint will receive an ongoing share of existing Newbury management fees making this a funded team lift.

Financial details are undisclosed.

Simpson Thacher & Bartlett LLP is serving as legal counsel and Campbell Lutyens as financial advisor to Bridgepoint. Latham & Watkins LLP is serving as legal counsel and Berkshire Global Advisors as financial advisor to Apollo in the transaction.

Raoul Hughes, Group Chief Executive of Bridgepoint, said:

“The addition of the Newbury team is a positive step in Bridgepoint’s evolution, as we continue to scale and diversify our platform. We have spent the past year evaluating the best route into secondaries, and the Newbury team brings proven expertise, strong relationships and an outstanding track record & data set which provides us with an attractive entry point from which to organically build a scaled platform.”

Chris Jaroch, Partner at Newbury Partners, added:

“We’re hugely excited to be joining Bridgepoint, a global leader in mid-market investing. With Bridgepoint’s strong brand and resources, combined with Newbury’s decades of experience in the secondaries space, we believe we can continue to build and scale a compelling, integrated platform for our investors.”

Bridgepoint Group is one of the world’s leading quoted private asset growth investors, specialising in private equity, infrastructure and private credit.

With over $86 billion of assets under management and a strong local presence in Europe, North America and Asia, we combine global scale with local market insight and sector expertise, consistently delivering strong returns through cycles.

Bridgepoint Advisers Limited, a subsidiary of Bridgepoint Group plc, is authorised and regulated by the Financial Conduct Authority.

Categories: News

Tags:

CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries

5Am Ventures

Collaboration to leverage CAMP4’s RAP Platform® to accelerate development of novel antisense oligonucleotides (ASOs) for neurodegenerative and renal diseases

CAMP4 to receive $17.5 million upfront and eligible for additional milestone-based payments, in addition to tiered royalties

CAMBRIDGE, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) — CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, has entered into a strategic research, collaboration and license agreement with GSK to identify and develop antisense oligonucleotide (ASO) drug candidates for multiple gene targets relevant to neurodegenerative and kidney disease indications.

“Protein under-expression plays a critical role in diseases such as neurodegenerative and kidney disease. Our collaboration with GSK, focused on the rapid identification of novel targets and potential ASO therapeutics that increase the expression of validated genetic targets, underscores the potential of our discovery platform to create transformational medicines for patients,” said Josh Mandel-Brehm, President and Chief Executive Officer of CAMP4.

Under the terms of the agreement, CAMP4 will receive a $17.5 million cash upfront payment. Additionally, CAMP4 has the potential to receive additional payments for certain development and commercial milestones, in addition to tiered royalties on future product sales.

CAMP4 will utilize its proprietary RAP Platform® to identify regRNAs controlling the expression of multiple gene targets and generate regRNA-targeting ASO candidates that amplify target gene expression for potential development. GSK will be responsible for the further development and commercialization of ASO drug candidates identified through the collaboration.

Chris Austin, SVP Research Technologies, GSK, said: “We are excited to collaborate with CAMP4, combining their RNA discovery platform to increase specific gene activity with GSK’s expertise in therapeutic oligonucleotides, genetics and advanced laboratory and data technologies. This agreement aims to drive the development of novel medicines for neurodegenerative and kidney disease and demonstrates our approach of harnessing cutting-edge technologies to deliver transformational therapies for patients.”

About CAMP4 Therapeutics 
CAMP4 is developing disease-modifying treatments for a broad range of genetic diseases where amplifying healthy protein may offer therapeutic benefits. Our approach amplifies mRNA by harnessing a fundamental mechanism of how genes are controlled. To amplify mRNA, our therapeutic ASO drug candidates target regulatory RNAs (regRNAs), which act locally on transcription factors and are the master regulators of gene expression. CAMP4’s proprietary RAP Platform® enables the mapping of regRNAs and generation of therapeutic candidates designed to target the regRNAs associated with genes underlying haploinsufficient and recessive partial loss-of-function disorders, of which there are more than 1,200, in which a modest increase in protein expression may have the potential to be clinically meaningful. For more information, visit camp4tx.com.

Forward-Looking Statements 
This press release contains forward-looking statements which involve risks, uncertainties and contingencies, many of which are beyond the control of the Company, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. All statements other than statements of historical facts contained in this press release are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements include, but are not limited to, statements concerning the development of ASO drug candidates for multiple gene targets relevant to neurodegenerative and kidney disease indications; the potential of the Company’s platform technology; the Company’s receipt of future contingent milestones and/or royalties; and the Company’s strategy, goals, business plans and focus. The forward-looking statements in this press release speak only as of the date of this press release and are subject to a number of known and unknown risks, uncertainties and assumptions that could cause the Company’s actual results to differ materially from those anticipated in the forward-looking statements, including, but not limited to: the Company’s limited operating history, incurrence of substantial losses since the Company’s inception and anticipation of incurring substantial and increasing losses for the foreseeable future; the Company’s need for substantial additional financing to achieve the Company’s goals; the uncertainty of clinical development, which is lengthy and expensive, and characterized by uncertain outcomes, and risks related to additional costs or delays in completing, or failing to complete, the development and commercialization of product candidates; delays or difficulties in the enrollment and dosing of patients in clinical trials; the impact of any significant adverse events or undesirable side effects caused by product candidates; potential competition, including from large and specialty pharmaceutical and biotechnology companies; the Company’s ability to realize the benefits of the Company’s current or future collaborations or licensing arrangements and ability to successfully consummate future partnerships; the ability to obtain regulatory approval to commercialize any product candidate in the United States or any other jurisdiction, and the risk that any such approval may be for a more narrow indication; the Company’s dependence on the services of the Company’s senior management and other clinical and scientific personnel, and the Company’s ability to retain these individuals or recruit additional management or clinical and scientific personnel; the Company’s ability to grow the Company’s organization, and manage the Company’s growth and expansion of the Company’s operations; risks related to the manufacturing of product candidates, which is complex, and the risk that third-party manufacturers may encounter difficulties in production; the Company’s ability to obtain and maintain sufficient intellectual property protection for current and future product; the Company’s reliance on third parties to conduct preclinical studies and clinical trials; the Company’s compliance with the Company’s obligations under the licenses granted to the Company by others, for the rights to develop and commercialize the Company’s product candidates; risks related to the operations of suppliers; and other risks and uncertainties described in the section “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, as well as other information the Company files with the Securities and Exchange Commission. The forward-looking statements in this press release are inherently uncertain and are not guarantees of future events. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond the Company’s control, you should not unduly rely on these forward-looking statements. The events and circumstances reflected in the forward-looking statements may not be achieved or occur and actual future results, levels of activity, performance and events and circumstances could differ materially from those projected in the forward-looking statements. Moreover, the Company operates in an evolving environment. New risks and uncertainties may emerge from time to time, and management cannot predict all risks and uncertainties. Investors, potential investors, and others should give careful consideration to these risks and uncertainties. Except as required by applicable law, the Company does not undertake to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Contacts

Investor Relations:
Sara Michelmore
Milestone Advisors
sara@milestone-advisorsllc.com

Media:
Jason Braco, Ph.D.
LifeSci Communications
jbraco@lifescicomms.com

Categories: News

Tags:

Empowering the Future of Energy: How exnaton is Leading Europe’s Electrification Shift

Elevator Ventures

Our portfolio company exnaton is driving electrification across Europe.

As Europe accelerates toward full-scale electrification, utilities are under increasing pressure to modernize their systems, launch innovative energy products, and meet rapidly evolving customer expectations. The rise of electric vehicles, rooftop solar and decentralized flexibility is transforming the energy market from a linear value chain into a dynamic ecosystem – one that demands smarter billing, transparent data andregulatory compliance at unprecedented scale.

Regulatory requirements are amplifying this shift. The EU Electricity Market Design law (Directive EU/2024/1711) has been transposed into national law, reshaping how Member States enable flexibility, consumer participation and dynamic pricing. This policy is underpinned by the continent-wide rollout of smart meters: Spain has reached 100% coverage, the Netherlands is above 95%, France is at 93%, and Austria has already surpassed roughly 95% of its meters by late 2024. Germany is targeting 95% by 2030 and Poland is moving toward 100% by 2031.

Utilities know change is unavoidable, and most recognize the challenge of moving fast enough in this new environment of electrification, flexibility and data-driven regulation.

This is where exnaton comes in.

A Real-World Challenge: Utilities Need Flexibility, not full IT Overhauls

Most utilities operate on legacy ERP systems built for a world of stable, predictable electricity flows. But dynamic tariffs, prosumer models, energy communities and smart electric vehicle charging require a more innovative approach to analyzing data coming from PoDs (Point of Delivery). The in-house development of capabilities, such as automated billing and seamless customer interfaces, is slow, expensive and often impractical.

Customers, meanwhile, increasingly expect transparency and personalization. Regulators demand accuracy and flexibility. Markets reward innovation.

exnaton bridges this gap with a modern intelligence layer that transforms existing infrastructure – without forcing utilities to rebuild it.

About exnaton: An Intelligence Platform Built for the New Energy System

Founded in Zurich in 2020, exnaton develops an AI-powered SaaS platform that helps utilities deploy next-generation energy products rapidly and at scale. Rather than replacing existing IT architecture, exnaton adds a modular, flexible intelligence layer that handles billingworkflows, dynamic pricing and data analysis.

Today, more than 50 utilities across Europe rely on exnaton’s technology – including examples such as TotalEnergies in Belgium, the E.ON brands eprimo, Bayernwerk in Germany, enersuisse in Switzerland, and Burgenland Energie in Austria – collectively demonstrating how exnaton enables both large multinational suppliers and regional champions to drive the digital transformation of the energy sector.

With research backgrounds from ETH Zürich, Stanford University, and University of St. Gallen, the team combines academic depth with practical industry expertise. Their mission is simple: empower utilities to deliver sustainable, data-driven energy products that make the energy transition tangible for every household.

Deep Dive: How the Platform Works – and why it matters

exnaton’s intelligence platform focuses onthree key areas that address the most pressing needs of today’s utilities:

AI-Enhanced Billing

Utilities can automate complex billing processes using granular, 15-minute energy data from smart meters. AI-powered processing ensures accuracy, reduces operational costs and minimizes manual reconciliation work – critical for dynamic tariffs and flexible grid fees.

Modular & Scalable Architecture

The platform integrates directly with existing ERP systems, enabling faster time-to-market for new, time-series-based energy products. Its modularity supports a wide range of use cases, from energy communities and peer-to-peer sharing to intelligent electric vehicle charging and prosumer billing.

White-Label Customer Experience

exnaton provides a customizable user interface that allows consumers to easily monitor their energy consumption, production and – where integrated – smart device activity. This transparency empowers customers to make data-driven decisions – and increases their engagement with sustainable products.

For utilities, this combination improves efficiency, unlocks new business models, and strengthens customer loyalty. For consumers, it makes the energy transition intuitive, accessible, and actionable.

Why Energy Tech: The “Beyond Banking” Trend

For Elevator Ventures, this is a crucial investment that aligns perfectly with our focus on “Beyond Banking” solutions in relevant areas like energy transition. The energy market represents a huge opportunity, particularly given Raiffeisen’s existing activities in the Austrian energy sector like Auri by Raiffeisenlandesbank Niederösterreich-Wien, Enlion and Raiffeisen Regenerative as well as the strong network of clients and partners in energy utilities across Austria and Central and Eastern Europe. As we see it, exnaton can play a leading role in the integration of finance into the future of energy.

Looking Ahead: Scaling Europe’s Decarbonized Grid

With its newly raised Series A financing, exnaton is poised to accelerate its European expansion and further develop AI-driven capabilities for real-time billing and decentralized and data-driven flexibility management.

Join us in Powering the Future

At Elevator Ventures, we believe in elevating the growth of founders who are building the infrastructure for tomorrow. By supporting exnaton, we are backing a team that is redefining how utilities innovate – and is ultimately accelerating the transition to a cleaner, smarterand more flexible energy system.

Learn more about exnaton: https://www.exnaton.ai/

picture of the exnaton software on phones

Categories: News

Tags:

IK Partners invests in Ascora

IK Partners

IK Partners (“IK”) is pleased to announce that the IK Small Cap IV Fund (“IK SC IV”) has acquired a majority stake in Ascora Group (“Ascora” or “the Group”), a French multi-specialist insurance broker, as part of a management buyout (“MBO”) designed to support its founder’s succession. IK has invested from its dedicated pool of Development Capital, with this transaction representing the fourth closed from IK SC IV, which held a final close on €2.0 billion in July 2025.

Founded in 1989 by Erik and Stéphane Henry, Ascora is one of the top 20 direct insurance brokers in France, offering end-to-end services from policy underwriting to claims management. Its expertise is organised across three main areas: Real Estate; Property & Casualty (“P&C”); and Health & Protection.

Largely operating in the Île-de-France region, Ascora serves over 12,000 clients. Grounded in technical depth and a people-centric culture built on proximity, trust and care, the Group has established a strong reputation for delivering highly personalised advice tailored to individual needs.

After more than three decades of leading the Group, Stéphane Henry wished to step back from his role as President. This transaction — led by IK with the support of both Stéphane and the management team — facilitates this transition and, as part of the MBO, enables the management team led by CEO Bruno Deschamps to increase its shareholding.

Ascora has successfully acquired 13 brokers to date and intends to continue executing a targeted buy-and-build strategy, leveraging IK’s Insurance Brokerage expertise built through its work with Yellow Hive (Netherlands), Ascentiel Group (France) and Seventeen Group (UK). Ascora also aims to strengthen its position as a leading insurance brokerage platform by accelerating growth in its core Real Estate and P&C segments, supported by investments in its sales team and digital tools. To ensure future scalability and effectiveness, it will look to further professionalise its central functions and strengthen its organisational structure.

Stéphane Henry, Founder of Ascora, said: “Over the past 30 years, we have focused on building a robust consolidation platform in the French insurance brokerage market and I am very proud of all that we have achieved together. As the Group enters the next phase of its journey with IK’s backing, I would like to thank everyone who has been instrumental in Ascora’s success to date and I look forward to supporting Bruno and the team in my new role on the Board.”

Bruno Deschamps, CEO of Ascora, added: “On behalf of the management team and everyone at Ascora, I would like to take this opportunity to thank Stéphane for his exceptional leadership over the past three decades. Our clients value the fact that we pick up the phone, fight their claims with the same determination we would apply to our own assets and provide genuine expertise — not just distribution. With IK as our partner, we will preserve everything that makes Ascora distinctive while expanding our presence and capabilities across France.”

Pierre Gallix, Managing Partner at IK and Advisor to the IK SC IV Fund, commented: “Ascora is a high-quality platform operating at the heart of resilient, high-growth real estate niches, supported by strong fundamentals such as recurring revenues, market-leading technical performance and an exceptionally skilled team. A hallmark of Ascora’s business model is its superior claims management capability, supported by a team of experienced legal professionals and in-house specialists. This approach has driven best-in-class loss ratios, high recovery rates and consistently strong outcomes for the Group’s clients. We are excited to partner with Bruno and his team on this next chapter and to accelerate the Group’s expansion through organic initiatives and bolt-on acquisitions.”

About Ascora

Founded in 1989 by Stéphane Henry, Ascora is one of the top 20 direct insurance brokers in France, offering end-to-end services from policy underwriting to claims management. Its expertise is organised across three main areas: Real Estate, Property & Casualty, and Health & Protection. For more information, please visit ascora.com

About IK Partners

IK Partners (“IK”) is a European private equity firm focused on investments in the Benelux, DACH, France, Nordics and the UK. Since 1989, IK has raised more than €20 billion of capital and invested in over 200 European companies. IK supports companies with strong underlying potential, partnering with management teams and investors to create robust, well-positioned businesses with excellent long-term prospects. For more information, visit ikpartners.com

Read More 

Categories: News

Tags:

Vantage Group Holdings to be acquired by Howard Hughes Holdings

Carlyle

Vantage’s Diversified Specialty Insurance Platform Delivers Lower Risk and Superior Return Potential

HHH to Host a Conference Call and Presentation on Thursday, December 18 at 8:30 a.m. ET, 

With an X Spaces Session to Follow

 

Hamilton, Bermuda December 17, 2025 – Vantage Group Holdings Ltd. (“Vantage”), a privately held leading specialty insurance and reinsurance company backed by Carlyle and Hellman & Friedman today announced that it has entered into a definitive agreement for Howard Hughes Holdings Inc. (NYSE: HHH) (“Howard Hughes,” “HHH,” or the “Company”) to acquire 100% of Vantage for $2.1 billion in cash or approximately 1.5x year-end 2025 book value. The transaction is expected to close in the second quarter of 2026, subject to customary regulatory approvals. Upon closing, Vantage will anchor Howard Hughes’ transformation into a diversified holding company.

Founded in 2020, Vantage has scaled into a next-generation leading specialty insurer and reinsurer, offering a diversified portfolio of global P&C products supported by modern infrastructure and advanced analytics.

“I’m excited about starting Vantage’s next chapter through this acquisition,” said Greg Hendrick, Chief Executive Officer of Vantage. “With Howard Hughes’ permanent capital and long-term vision, we expect to strengthen our balance sheet and expand opportunities in specialty insurance, reinsurance, and partnership capital. After closing, we anticipate enhanced resources to fuel profitable growth, drive innovation, and deliver even greater value to brokers and clients over time. None of this would be possible without the amazing passion and energy of 360 colleagues, the unwavering support of Carlyle and Hellman & Friedman, and the incredible support of our brokers and clients.”

Strategic Benefits of the Transaction:

  • Vantage will continue to operate with the same name, brand, and culture, with our colleagues retaining the same roles, teams, and go-to-market strategy.
  • HHH’s holding-company ownership of Vantage provides long-term capital support which materially strengthens Vantage’s credit profile and underwriting flexibility. An emphasis on underwriting profitability—driven by disciplined risk selection, pricing, and portfolio optimization rather than growth—will allow Vantage to effectively navigate the insurance cycle and optimize asset allocation over time.
  • Pershing Square will manage Vantage’s assets on a fee-free basis, enhancing investment returns and furthering alignment with policyholders and shareholders. Over time, Vantage’s investment portfolio will be directly invested in cash, short-term Treasurys, high-quality fixed-maturity securities, and a portfolio of common stocks subject to rating agency and regulatory considerations.

Jim Burr, Co-Head of Global Financial Services at Carlyle, and Jitij Dwivedi, Partner in the Financial Services team at Carlyle, said: “We are proud to have partnered with Greg Hendrick and the entire Vantage management team over the past five years and support the launch and build-out of the business. Together, we have built a top tier specialty insurance and re-insurance business, differentiated by its culture and tech-enabled underwriting platform, delivered strong earnings growth and diversified Vantage’s business model through innovative insurance-linked strategies. We think Howard Hughes will be a great home and wish Greg and the Vantage team continued success as it enters its next phase of growth.”

“We are so proud of what Greg and the team have built since we launched together in 2020. Today, Vantage is a high-quality insurance and reinsurance franchise with an excellent team and deep underwriting capabilities. We look forward to watching its continued growth and success in its next chapter,” said Adam Halpern-Leistner, Partner at Hellman & Friedman, and Hunter Philbrick, Partner at Hellman & Friedman.

Conference Call and X Spaces Session Information

HHH Executive Chairman Bill Ackman, CIO Ryan Israel, and CEO David O’Reilly will discuss the Vantage acquisition on a conference call tomorrow morning, Thursday, December 18, at 8:30 a.m. ET. The call will be followed by an X Spaces Session, with a town hall format open to the public providing the opportunity for participants to ask questions and engage in dialogue with HHH’s executive leadership.

To listen to the conference call and view the accompanying presentation via a live webcast, please visit the Howard Hughes website. Listeners who wish to participate in the question-and-answer session may do so via telephone by pre-registering on HHH’s event registration webpage.

The X Spaces session will be available at https://x.com/BillAckman

Advisors

J.P. Morgan Securities LLC is acting as exclusive financial advisor to Vantage. Debevoise & Plimpton LLP is acting as legal counsel. Jefferies LLC is acting as financial advisor to Howard Hughes Holdings, and Latham & Watkins are acting as legal counsel. Oliver Wyman is acting as the Company’s actuarial advisor.

About Vantage Group Holdings

Vantage Group Holdings Ltd. (Vantage) was established in late 2020 as a re/insurance partner designed for the future. Driven by relentless curiosity, the Vantage team of trusted experts provides a fresh perspective on clients’ risks and adds creativity to tech-enabled efficiency and robust analytics to address risks others avoid. Vantage operating subsidiaries Vantage Risk Ltd., Vantage Risk Assurance Company and Vantage Risk Specialty Insurance Company are rated “A-” (Stable) by AM Best and “A-” (Stable) by S&P Global Ratings. Founded with support from Carlyle and Hellman & Friedman, global investment firms with deep experience in the re/insurance industry, Vantage has grown into a leading provider of specialty insurance, reinsurance, and partnership capital solutions. Additional information about Vantage can be found at www.vantagerisk.com.

About Howard Hughes Holdings
Howard Hughes Holdings Inc. (HHH) is a holding company focused on growing long-term shareholder value. Through its real estate platform, Howard Hughes Communities, HHH owns, manages, and develops commercial, residential, and mixed-use real estate throughout the U.S. Its award-winning assets include the country’s preeminent portfolio of master planned communities, as well as operating properties and development opportunities including The Woodlands®, Bridgeland® and The Woodlands Hills® in the Greater Houston, Texas area; Summerlin® in Las Vegas; Teravalis™ in the Greater Phoenix, Arizona area; Ward Village® in Honolulu, Hawaiʻi; and Merriweather District in Columbia, Maryland. Howard Hughes Holdings Inc. is traded on the New York Stock Exchange as HHH. For additional information visit www.howardhughes.com.

About Carlyle

Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across its business and operates through three segments: Global Private Equity, Global Credit, and Carlyle AlpInvest. With $474 billion of assets under management as of September 30, 2025, Carlyle’s purpose is to invest wisely and create value on behalf of its investors, portfolio companies, and the communities in which we live and invest. Carlyle employs more than 2,400 people in 27 offices across four continents. Further information is available at carlyle.com. Follow Carlyle on LinkedIn at The Carlyle Group and on X at @OneCarlyle.

About Hellman & Friedman 

Hellman & Friedman is a preeminent global private equity firm with a distinctive investment approach focused on a limited number of large-scale equity investments in high-quality growth businesses. H&F seeks to partner with world-class management teams where its deep sector expertise, long-term orientation, and collaborative partnership approach enable companies to flourish. H&F targets outstanding businesses in select sectors, including technology, financial services, healthcare, consumer services & retail, and information, content & business services. Since its founding in 1984, H&F has invested in over 100 companies and has over $120 billion in assets under management as of September 30, 2025. Learn more about H&F’s defining investment philosophy and approach to sustainable outcomes at www.hf.com.

Safe Harbor Statement

Statements made in this press release that are not historical facts, including statements accompanied by words such as “will,” “believe,” “expect,” “enables,” “realize,” “plan,” “intend,” “assume,” “transform” and other words of similar expression, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on management’s expectations, estimates, assumptions, and projections as of the date of this release and are not guarantees of future performance. Actual results may differ materially from those expressed or implied in these statements. Factors that could cause actual results to differ materially are set forth as risk factors in Howard Hughes Holdings Inc.’s filings with the Securities and Exchange Commission, including its Quarterly and Annual Reports. Howard Hughes Holdings Inc. cautions you not to place undue reliance on the forward-looking statements contained in this release. Howard Hughes Holdings Inc. does not undertake any obligation to publicly update or revise any forward-looking statements to reflect future events, information or circumstances that arise after the date of this release.

 

###

 

Media Relations:

John Flannery

Vantage Risk

john.flannery@vantagerisk.com

203-918-7151

Categories: News

Tags:

Ethos Capital Completes Continuation Vehicle for Identity Digital

CVC Capital Partners

New investment partners join to support company’s next phase of growth

Ethos Capital LP (Ethos) announced today that it has completed a continuation vehicle (CV) transaction for its portfolio company Identity Digital, bringing in institutional investors including TPG GP Solutions, funds managed by Neuberger, Accel-KKR, Coller Capital, and CVC Secondary Partners, British Columbia Investment Management Corporation (BCI), and 10 East, among others. The transaction enables Ethos to support Identity Digital’s next stage of growth, while offering existing investors the opportunity for liquidity.

“This transaction reflects our conviction in Identity Digital’s long-term potential,” said Erik Brooks, Co-Founder and Managing Partner of Ethos Capital. “We’re grateful to our new investment partners for joining us in this next phase and to our existing investors for their continued trust. Identity Digital’s leadership team has built a performant company that sits at the center of the digital-identity ecosystem, and we’re excited to support their next chapter. Ethos is committed to a long-term investment strategy that employs our deep operational experience to drive long-term profitability and growth.”

Identity Digital operates mission-critical internet domain name system infrastructure that powers trusted online identity and helps organizations establish and secure their digital presence. Since Ethos’ initial investment in 2021, the company has expanded its platform, integrated acquisitions and continued to innovate in response to evolving market opportunities.

“This new investment affirms the strength of our business and supports our continued focus on innovation and client success,” said Akram Atallah, CEO of Identity Digital. “We look forward to deepening our partnership with Ethos and welcoming our new investors as we pursue our next stage of growth.”

“We are delighted to partner with Ethos and the Identity Digital management team for the next chapter of the company’s growth,” said Michael Woolhouse, Co-Managing Partner TPG GP Solutions. “Internet and digital infrastructure has been a key thematic focus area for TPG for over a decade, and Identity Digital has established itself as a clear market leader within this highly attractive market.”

“Neuberger Private Markets has a longstanding, successful partnership with Ethos Capital,” said Frank Guglielmo, Managing Director of Neuberger. “We continue to be impressed with Ethos’ thoughtful approach to value creation. As an existing shareholder in Identity Digital, we are excited to continue supporting the company’s strategic growth through the continuation vehicle transaction.”

Categories: News

Tags:

Partner Promotions 2026

eqt

EQT’s success starts and ends with our people. The annual promotions to the EQT Partnership are the result of a thoughtful, multi-year assessment of leadership, investment excellence, long-term contribution, and unwavering commitment to EQT’s values.

This year, we are happy to invite the following colleagues to the partnership:

Capital Raising & Capital Markets

  • Martin Donnelly, based in Sydney.
  • Nick Thorn, based in Hong Kong.

Deal Services

  • Petter Weiderholm, based between Singapore and Stockholm.

Infrastructure

  • Benjamin Bygott-Webb, currently based in New York (on relocation from London).
  • Guillermo García-Barrero based in Madrid.
  • Patrick Jaslowitzer, based in Paris.

Private Capital

  • Adam Scheid, based in Stockholm.
  • Michiel Thiessen, based in London.
  • Tyler Parker, based in San Francisco.

Real Estate

  • Brian Serpico, based in Philadelphia.
  • Joerg Kreindl, based in Vienna.
  • Steven Stein, based in Columbus.
  • Thomas Meehan, based in Philadelphia.

Categories: People

Trading Technologies Acquires OpenGamma, Leader in Margin and Capital Optimization Analytics

Thomabravo

CHICAGO and LONDON—Trading Technologies International, Inc. (TT), a global capital markets technology platform services provider, today announced it has acquired OpenGamma, a market leader in derivatives margin analytics for buy-side and sell-side clients. Terms of the transaction were not disclosed.

The integration of OpenGamma’s sophisticated margin optimization and capital efficiency tools directly into the TT platform will allow for automated trading and position transfer workflows that reduce risk and increase efficiency and will significantly enhance TT’s multi-asset platform.

Justin Llewellyn-Jones, CEO of TT, said: “The acquisition of OpenGamma is a transformative step that immediately deepens the value proposition we will offer our combined customer base. Global derivatives markets have undergone profound structural changes in recent years, particularly in the realm of margin requirements, resulting in an acute need to manage margin-driven liquidity risk without weakening safeguards around counterparty risk. OpenGamma’s real-time insights empower firms to maximize leverage and free up precious capital. This is a crucial strategic addition that aligns perfectly with our mission to provide the best multi-asset platform experience across the entire trade life cycle.”

Peter Rippon, CEO of OpenGamma, said: “Joining forces with Trading Technologies provides us with a massive opportunity to accelerate our growth. Leveraging TT’s scaled go-to-market and distribution capabilities will unlock new opportunities for the OpenGamma platform across the Americas, Europe, the Middle East and Asia-Pacific regions. Our team is excited to integrate our leading analytics into the TT platform, bringing new capital efficiencies to a much broader audience. I would like to thank the OpenGamma team and our investors for their unwavering commitment and support over the last 10 years.”

OpenGamma’s platform boasts a significant footprint, with top-tier clients across hedge funds, commodities trading firms and sell-side banks. TT will leverage OpenGamma’s strong client relationships to accelerate its opportunities in the hedge fund and energy sectors, while TT’s extensive network will provide OpenGamma with access to a larger pool of sell-side bank clients.

The TT platform handled more than 2.9 billion derivatives transactions so far in 2025. Through its Execution Management System (EMS), TT provides access to more than 100 global exchanges and venues for cross-asset trading. Through TT’s Order Management System (OMS), firms can accept, manage and execute orders and conduct post-trade confirmations and allocations. The expansion of the platform to deliver multi-asset functionality enables clients to utilize sophisticated order and execution management tools in the E/OMS for high-, low- and no-touch workflows across their global trading operations in each of the asset classes. TT’s open architecture allows users to integrate their systems with TT to access their own market connections, private liquidity or execution algorithms and import data from external sources enterprise-wide.

Houlihan Lokey served as exclusive financial advisor and Gunderson Dettmer as legal advisor to OpenGamma. Goodwin Procter served as legal advisor to Trading Technologies, Thoma Bravo and 7RIDGE.

About Trading Technologies

Trading Technologies is a global capital markets platform services company providing market-leading technology for the end-to-end trading operations of Tier 1 banks, brokerages, money managers, hedge funds, proprietary traders, Commodity Trading Advisors (CTAs), commercial hedgers and risk managers. With its roots in listed derivatives, the Software-as-a-Service (SaaS) company delivers “multi-X” solutions, with “X” representing asset classes, functions, workflows and geographies. This multi-X approach features trade execution services across futures and options, fixed income, foreign exchange (FX) and cryptocurrencies augmented by solutions for data and analytics, including transaction cost analysis (TCA); quantitative trading; compliance and trade surveillance; clearing and post-trade allocation; and infrastructure services. The award-winning TT platform ecosystem also helps exchanges deliver innovative solutions to their market participants, and technology companies to distribute their complementary offerings to Trading Technologies’ clients.

About OpenGamma

OpenGamma is a derivatives analytics firm with unparalleled expertise in over-the-counter (OTC) and exchange-traded derivatives (ETD) and prime broker margin methodologies. Its teams bring together a unique mix of practitioner, quantitative and software engineering expertise. Today, OpenGamma is trusted by the largest and most sophisticated global banks and fund managers, with thousands of users depending on its analytics. OpenGamma has been backed by Accel, CME Ventures, Dawn Capital, Allianz X and Cristóbal Conde.

Categories: News

Tags: